The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000359:Aftercare; D000368:Aged; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D004651:Employment; D005260:Female; D005476:Fluphenazine / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007267:Injections; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D010359:Patient Readmission; D012008:Recurrence; D012559:Schizophrenia / Q000188:drug therapy*; D012651:Self Medication; D012917:Social Adjustment; D012936:Social Medicine
D003692:Delayed-Action Preparations; D005476:Fluphenazine